Companies: 10,795·Total market cap: $144.5T
Jupiter Neurosciences, Inc.

Jupiter Neurosciences, Inc.

JUNSNASDAQHealthcare● Active
$0.23
$-0.00(-0.65%)
Market Cap$8362057
P/E Ratio
52W High$3.33
52W Low$0.172

Jupiter Neurosciences, Inc. (JUNS) Revenue

Annual & quarterly revenue history · segment & region breakdown

JUNS · revenue · updated Jun 9, 2026

Core revenue metrics

Jupiter Neurosciences, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
$0K
4 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Jupiter Neurosciences, Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
JUNS revenue by year · JUNS revenue history · JUNS annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Jupiter Neurosciences, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Jupiter Neurosciences, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Jupiter Neurosciences, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

JUNS revenue · 4 questions

JUNS's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

JUNS revenueJUNS annual revenuewhat is JUNS revenueJUNS TTM revenue

Source: FMP · Jupiter Neurosciences, Inc. SEC filings · GAAP · Jupiter Neurosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026